Gene · 644079
Papers2,404
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,404
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metal-organic frameworks as therapeutic chameleons: revolutionizing the cancer therapy employing novel nanoarchitectonics. | Asian J Pharm Sci | 2025 | 41809260 | PubTator, text mining | PubMed |
| Profiling the Complexity of Resistance Factors in Cancer Cells Towards Berberine and Its Derivatives. | Pharmaceuticals (Basel) | 2025 | 41599627 | PubTator, text mining | PubMed |
| Results from a prospective registry of 18F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET. | Am J Nucl Med Mol Imaging | 2025 | 41567835 | PubTator, text mining | PubMed |
| Integrating whole-exome sequencing and scRNA-seq reveal the characteristic in one clear cell renal cell carcinoma sample arising in the setting of VHL disease. | Sci Rep | 2025 | 41413084 | PubTator, text mining | PubMed |
| AFP promotes cancer multidrug resistance through activating PI3K/Akt/NF-κB signaling pathway. | Sci Rep | 2025 | 41318819 | PubTator, text mining | PubMed |
| [CircRAD18 Regulates Daunorubicin Resistance in Acute Myeloid Leukemia Cells through MiR-185-5p/HDGF Axis]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 41234080 | PubTator, text mining | PubMed |
| Exosomes in cancer metabolism and drug resistance: A review. | Biomol Biomed | 2025 | 41190394 | PubTator, text mining | PubMed |
| Profiling Interactions Between Bicyclol and SLC/ABC Transporters: Advancing Clinical Safety and Efficacy in Combination Therapy. | Pharm Res | 2025 | 41145746 | PubTator, text mining | PubMed |
| Reproducibility and transparency: why following MISEV guidelines is beneficial for the studies on EVs and brain barriers. | Extracell Vesicles Circ Nucl Acids | 2025 | 41132499 | PubTator, text mining | PubMed |
| Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations. | Nucleic Acids Res | 2025 | 41020498 | PubTator, text mining | PubMed |
| Comparing the Altis RepliGut Organoid System to MDCK Monolayers in Predicting the Oral Absorption of Lenalidomide. | Pharmaceutics | 2025 | 41012477 | PubTator, text mining | PubMed |
| Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer. | Cells | 2025 | 41002447 | PubTator, text mining | PubMed |
| Imaging microtubule dynamics: A new frontier in biomarker development for neurodegenerative diseases. | Alzheimers Dement | 2025 | 40985270 | PubTator, text mining | PubMed |
| [Layered double hydroxide-loaded si-NEAT1 regulates paclitaxel resistance and tumor-associated macrophage polarization in breast cancer by targeting miR-133b/PD-L1]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | 40916533 | PubTator, text mining | PubMed |
| Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series. | Nat Commun | 2025 | 40897730 | PubTator, text mining | PubMed |
| Serum biomarkers of delirium in critical illness: a systematic review of mechanistic and diagnostic evidence. | Intensive Care Med Exp | 2025 | 40889075 | PubTator, text mining | PubMed |
| Development of PBPK Population Model for End-Stage Renal Disease Patients to Inform OATP1B-, BCRP-, P-gp-, and CYP3A4-Mediated Drug Disposition with Individual Influencing Factors. | Pharmaceutics | 2025 | 40871097 | PubTator, text mining | PubMed |
| Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphoma. | Blood Cancer J | 2025 | 40858552 | PubTator, text mining | PubMed |
| Rosuvastatin PBPK Modeling: Incorporating Liver Concentrations and Effects of Ethnicity, Genetic Polymorphisms, Lactone Formation, DDI and Pregnancy. | CPT Pharmacometrics Syst Pharmacol | 2025 | 40855563 | PubTator, text mining | PubMed |
| GLUT3 enhances chemosensitivity in glioblastoma by transporting temozolomide and capecitabine. | Cell Death Discov | 2025 | 40813374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/644079/papers?page=4